NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$1.92
0.05 (2.67%)
▲
5d:
+10.98%
30d:
+131.33%
90d:
+139.67%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 28, 2026
28d
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NIVF is 9.7% above fair value ($1.75). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NIVF is 9.7% above fair value ($1.75). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.73
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$16.60
88.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $1.92, which is considered extended relative to its 30-day fair value range of $0.55 to $1.75. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.0) compared to its historical average (0.2). Remarkably, the market is currently pricing in an annual earnings decline of 51.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a uptrend. Immediate support is located at $1.52, while resistance sits at $2.29.
Market Sentiment: NIVF has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $900.00 (+48028.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NIVF is in a uptrend. Immediate support is located at $1.52, while resistance sits at $2.29.
Market Sentiment: NIVF has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $900.00 (+48028.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.55 -
$1.75
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.4%
All Signals
- BEARISH: Price extended above range (+9.7% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 48028.3% below Wall St target ($900.00)
Fair Price Analysis
30-Day Fair Range
$0.55 -
$1.75
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.52
Resistance Level
$2.29
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.02
Wall Street Target
$900.00
(+48028.3%)
Revenue Growth (YoY)
-12.9%
Profit Margin
381.2%
Valuation Discount vs History
-51.5% cheaper
PE vs Historical
0.0 vs 0.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-51.5%
(market-implied from PE analysis)
1-Year Target
$1.68
(-10%)
2-Year Target
$1.51
(-19%)
3-Year Target
$1.36
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$13.91
(+644%)
📈
Valuation based on Current Earnings
Trailing PE: 0.00 | Current EPS (TTM): $486.09
Bull Case
$0.91
(-48%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.83
(-52%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$1.12
(-35%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.0 to 0.2
Stabilization Target:
$19.08
(+920.3%)
PE Expansion Potential:
+920.3%
Share & Embed Analysis
Last updated: March 30, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
Data refreshes hourly during market hours. Next update: 3:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
